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Abstract 
The objective of this study was to analyze the effect of intervention with rice bran oil-emulsion beverage on 
serum triglycerides, HDL-c, and blood pressure in men with metabolic syndrome aged 35-60 years. This study 
used a double-blind randomized controlled trial design. The subjects were assigned into two groups, i.e. 19 
people in the intervention group who were given rice bran oil-emulsion beverage equivalent to 28.80 mg 
oryzanol/glass, two glasses a day for four weeks; and 17 people in the control group who were given placebo 
beverage in the same quantity. The results showed that trend increase in serum HDL-c and  decrease  blood 
pressure of the intervention group after intervention, although they were not significantly different from the 
control group (p>0.05). Intervention using rice bran oil-emulsion had the potential of preventing the 
development of metabolic syndrome. 
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1. Introduction 
Incidence of diseases and causes of death in Indonesia nowadays have shifted, in which non-communicable 
disease (NCD) trend increases more rapidly but the incidence of infectious disease is still quite high. Types of 
NCDs with high prevalence are hypertension, coronary heart disease (CHD), type 2 diabetes mellitus, and 
cancer [1,2]. Progression of these diseases is in line with the development of obesity and metabolic syndrome.  
Metabolic syndrome is part of a number of risk factors that causes myocardial infarction and diabetes mellitus. 
Its global prevalence is quite high, i.e. 20-25% of the adult population. Meanwhile, its prevalence in the US and 
Chinese population are 22.90% and 23.20%, respectively [3-5]. The prevalence reaches 10-30% in Asia and 
28.4% in Indonesia [6,7]. Metabolic syndrome is multidimensional risk factor for cardiovascular disease. It has 
several criteria, one of which is defined by International Diabetes Federation (IDF). The criteria for metabolic 
syndrome according to IDF consensus in 2006 are having central obesity defined by certain ethnic specific 
values of waist circumference, was added with two of four other clinical signs. The physical symptom of 
metabolic syndrome is obesity or overweight characterized by increased waist circumference or body mass 
index (BMI). The biochemical symptoms are characterized by increased level of triglycerides (TG) and blood 
glucose, decreased serum high-density lipoprotein cholesterol (HDL-c) levels and increased blood pressure. The 
combination of various metabolic or clinical disorders can be ascertained to be far more instrumental in causing 
cardiovascular disease than any of the stand-alone disorders [8,9].  HDL-c has anti -oxidative molecules which 
has the potential to inhibit lipid oxidation. HDL-c levels may be decreased due to oxidative stress. Its ability to 
remove cholesterol from peripheral tissues is evidently suppressed by oxidative stress such as excessive intake 
of fat and carbohydrates, obesity, and increased chronic low-grade inflammation characterized by an increase in 
tumor necrosis factor alpha (TNF-α) levels. Therefore, the quantity and quality of HDL-c need to be maintained 
in order not to decrease. Failure to do so will result in the increased incidence of cardiovascular disease [10-12].   
Many functional foodstuffs found nowadays contain bioactive components that are useful for improving body 
function, thereby protecting us from diseases. Several studies have shown that bioactive components of fruits 
and vegetables contain dietary fibers and are high in antioxidants compound; thus, beneficial to health. One of 
these bioactive components contained in the functional foodstuffs is oryzanol. Oryzanol is a bioactive 
component in rice bran oil (RBO) which has antioxidant properties. It has been proven scientifically to maintain 
health and improve lipid profiles, as well as blood glucose in obese people [13-16]. This study aimed to analyze 
the effect of intervention RBO emulsion on TG levels, HDL-c levels and blood pressure. 
2. Materials and Methods 
2.1. Materials 
The materials used in this study were RBO, sugar ester, carboxymethylcellulose (CMC), sucralose, salt, 
flavoring and water. Emulsion beverage was made by mixing the RBO with sugar ester, CMC and water; then 
homogenized at a speed of 1000 rpm for 15 minutes.  
The emulsions obtained were diluted with water and then the sucralose and salt were added. The flavoring was 
added in the final stage and the products were put into the labeled packages. These emulsion beverages 
contained active ingredients equivalent to 28.80 mg oryzanol/glass.    
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2.2. Methods 
2.2.1. Design, location and time of study 
This was a double-blind randomized controlled trial. The selected subjects should met the inclusion criteria and 
were willing to sign informed consent. The subjects were gathered at the first meeting to be given an 
explanation of this study’s benefits. This study was conducted in Mintohardjo Navy Hospital in Central Jakarta, 
from August 2014 to July 2015. It passed the ethical review conducted by Ethics Committee of Faculty of 
Medicine, University of Indonesia Number: 870/UN2.F1/ETIK/2014. 
2.2.2. Research subjects 
The target population were obese men, aged ≥ 35 years, working in Mintohardjo Navy Hospital in Jakarta and 
Cilangkap Navy Public Health Office in West Java. The subjects met the criteria for metabolic syndrome 
defined by IDF in 2006, as follows: obese men aged 35-60 years; waist circumference > 90 cm; had two other 
clinical signs that matched with the criteria (TG > 150 mg/dL, HDL-c < 40 mg/dL, fasting blood glucose levels 
≥ 100 mg/dL, systolic blood pressure ≥ 130 mmHg and diastolic ≥ 85 mmHg). Subjects who used diabetes, 
heart disease, and antihypertensive medications were excluded.  Minimum number of subjects was calculated by 
using a minimum sample size formula for estimating mean differences between groups. Minimum number of 
subjects in each group based on the values of TG and HDL-c levels in the previous studies were 16 and 3 
people, respectively. Therefore, we chose the larger minimum sample size (16 people). To anticipate the 
possibility of drop-out, 5 people were added to each group. Therefore, the total subjects for each group became 
21 people. Randomization was performed at the beginning of study to determine the treatment to be received. 
The subjects in the intervention group received emulsion beverages containing 28.80 mg oryzanol/serving twice 
a day, while the ones in the control group received placebo beverages twice a day. At the end of study, only the 
data from 19 people in the intervention group and 17 people in the control group complited so that could be 
analyzed.      
2.2.3. Biochemical analysis  
Venous blood sampling was performed after the subjects did a 10-hour fasting. Venous blood samples (5 ml) 
were collected by medical personnel at the beginning and end of the intervention. Serum lipid profiles were then 
analyzed by DSI kits Number 60111321 and 60111509, while the blood glucose was analyzed by DSI kit 
Number 60108392. The results were interpreted by using UV-Vis spectrophotometer. Blood pressure was 
measured by using a mercury sphygmomanometer, at the beginning and end of the intervention. 
2.2.4. Statistical analysis 
We performed bivariate analysis on the data of biochemical analyses (pre- and post- intervention) and presented 
the results in tabular form. The next analysis was independent sample t-test to analyze the data of biochemical 
analyses between the intervention and control groups. The results were considered as significantly different if p-
value < 0.05. 
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3. Results and Discussion 
3.1. Subjects’ biochemical characteristics by group 
Table 1: Subjects’ biochemical characteristics by group 
Variable Control (n=17) Intervention (n=19) 
TG (mg/dL) 246.59 ± 112.19 191.00 ± 97.21 
HDL-c (mg/dL)   33.59 ± 7.77   33.47 ± 6.54 
Blood glucose   92.29 ± 25.36   94.26 ± 36.09 
Blood pressure   
Systolic 129.41 ± 17.48 126.32 ± 14.98 
Diastolic   85.00 ± 9.35    86.58 ± 8.98 
 
Our results showed that subjects’ serum TG and HDL-c levels in the control group were higher than the ones in 
the intervention group. Serum glucose levels in the control group were lower than the intervention group. 
Systolic blood pressure in the control group was higher than the intervention group, while diastolic blood 
pressure in the intervention group was higher than the control group. These results were not statistically 
significant (p>0.05). 
Metabolic syndrome accompanied with visceral obesity are closely related to insulin resistance. It may lead to 
hypertension, high levels of serum TG, low levels of serum HDL-c and hyperglycemia; which is in turn 
associated with cardiovascular disease. The diseases caused by these conditions (i.e. type 2 diabetes mellitus and 
CHD) occur with the increasing BMI and visceral fat [3,17].  
3.2. The Effect of intervention with RBO-emulsion beverage on serum triglyceride levels in men with 
metabolic syndrome 
Table 2: Effect of intervention with RBO-emulsion on serum triglycerides 
Subject’s group Serum triglycerides (mg/dL) 
Before intervention After intervention Difference  
Control group 246.59 ± 7.77 214.18 ± 150.93 -32.41 ± 131.59a 
Intervention group 191.00 ± 97.21 206.42 ± 127.03 15.42  81.03a 
 
a Figures followed by the same letters in the different row showed no significant difference between groups 
(p>0.05) 
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Table 2 showed a decline in mean serum TG levels in the control group and an increase in the mean serum 
levels in the intervention group. However, the magnitude of change in serum TG levels in both groups was not 
significant. In this research consumption of subjects are the same as before intervention. They Serum TG level 
in the intervention group did not decrease after the intervention, while the serum level in the control group 
decreased but was still above the normal values. It was due to the fat intake that was still within the limit of 
requirement values; thus, the active ingredient contained in rice bran was not able to work to decrease serum TG 
levels.  
Our results were not in line with the previous studies and several other researches indicating that rice bran 
intervention, either in the form of powder or oil-emulsion beverage, was able to decrease serum TG levels in the 
blood, either in animals or humans [18,19].  
Another study showed that vitamin E (tocopherol and tocotrienol) contained in RBO was only effective in 
decreasing low-density lipoprotein (LDL) and total cholesterol by inhibiting the enzyme activity of β-hydroxy-
β-methylglutaryl coenzyme A (HMG-CoA). Therefore, the fat was not synthesized by the body and 
cardiovascular disease could be prevented [18]. 
Our findings were in line with the previous study related to RBO intervention, which indicated that the use of 
RBO-emulsion beverage on obese people could decrease serum LDL and total cholesterol levels. However, 
serum glucose and TG levels remained unchanged after the intervention [20]. 
Another study on the intervention using rice bran porridge in elementary school students indicated that there 
was a significant increase in serum TG levels in the intervention group (p=0.014). Mean while, there was a 
decrease in the serum TG levels in the control group although not significant (p=0.012) [21].  
3.3. The Effect of intervention with RBO-emulsion beverage on serum HDL-c levels in men with metabolic 
syndrome 
Table 3: Effect of intervention with RBO-emulsion on HDL-c 
Subject’s group Serum HDL-c levels (mg/dL) 
Before intervention After intervention Difference  
Control group 33.59 ± 7.77 35.82 ± 8.31 2.24 ± 4.86a 
Intervention group 33.47 ± 6.54 34.53 ± 9.31 1.05 ± 4.96a 
 
a Figures followed by the same letters in the different row showed no significant difference between groups 
(p>0.05) 
Mean serum HDL-c levels in the control group before and after the intervention were higher than the 
intervention group.  There was an increase in serum HDL-c levels in both groups but not significant. 
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This study showed that there was an increase in serum HDL-c levels after intervention. Several other studies 
indicated an increase in serum HDL-c levels after rice bran intervention. It was due to the bioactive components 
in rice bran (γ oryzanol and ferulic acid) that had potent antioxidant activities. In addition, monounsaturated 
fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) contained in RBO could increase serum HDL-c 
levels in the blood [17,22]. 
Besides the reasons above, the increase in serum HDL-c levels might also be caused by the frequency and type 
of exercise performed by the subjects during this study. The subjects performed the exercise at least twice a 
week and they did various kinds of sport.  
This exercise contributed to the increased serum HDL-c levels among people with metabolic syndrome. As we 
have already known, HDL-c level can also be improved by doing physical activities. It is not only affected by 
dietary intake [23].  
3.4. The Effect of intervention with RBO-emulsion beverage on systolic blood pressure in men with metabolic 
syndrome 
Table 4: Mean values of systolic blood pressure by subject’s group 
Subject’s group Systolic blood pressure (mmHg) 
Before intervention After intervention Difference  
Control group 129.41 ± 17.48 126.47 ± 10.57 -2.94 ± 0.40a 
Intervention group 126.32 ± 14.98 121.58 ± 12.14 -4.74 ± 0.13a 
 
a Figures followed by the same letters in the different row showed no significant difference between groups 
(p>0.05) 
Mean systolic blood pressure in the control group before and after the intervention were higher than the 
intervention group. The values were almost normal but not significant. 
According to the IDF criteria in 2006, men with metabolic syndrome are defined as having hypertension if the 
systolic blood pressure ≥ 130 mmHg and diastolic blood pressure ≥ 85 mmHg.  
Increased blood pressure may occur through three main points, i.e. autonomic nervous system (ANS) disorders, 
insulin resistance, and abnormal structure and function of the blood vessels. Those three things can influence 
one another [24].    
3.5. The Effect of intervention using RBO-emulsion beverage on diastolic blood pressure in men with 
metabolic syndrome 
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Table 5: Mean values of diastolic blood pressure by subject’s group 
Subject’s group Diastolic blood pressure (mmHg) 
Before intervention After intervention Difference  
Control group 85.00 ± 9.35 85.88 ± 7.95       0.00 ± 0.70a 
Intervention group 86.58 ± 8.98             82.11 ± 9.76   -4.47 ±0.13a 
 
a Figures followed by the same letters in the different row showed no significant difference between groups 
(p>0.05) 
The mean diastolic blood pressure in the control group before the intervention was lower than the intervention 
group. After the intervention, the mean in the control group was higher than the one in the intervention group. 
The mean in the intervention group decreased toward normal value but it was not significant.  
This study showed a decline in systolic and diastolic blood pressure. It might be due to antioxidant, MUFA and 
PUFA contents in rice bran, in which each of these active ingredients was effective in lowering blood pressure if 
it is contained in foodstuffs [24].   
This study has strength and limitation. The strength of our study lies in the ability of RBO-emulsion which 
evidently has a tendency to increase HDL-c levels and decrease blood pressure after being analyzed. It can be 
assumed that intervention using RBO-emulsion beverage in men with metabolic syndrome may prevent the 
development of cardiovascular disease. This study’s limitation lies in the small sample size, due to the difficulty 
of finding the subjects with the specified criteria. 
4. Conclusion and Recommendation 
Intervention using RBO emulsion tends to improve serum HDL-c levels and decrease systolic and diastolic 
blood pressure. There were no changes in serum TG levels.  
It is recommended to use functional foodstuffs (e.g. rice bran beverage) and do regular physical activities, so 
that the development of metabolic syndrome can be diminished.   
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